✦ LIBER ✦

Minimal residual disease monitoring in chronic lymphocytic leukaemia patients. A comparative analysis of flow cytometry and ASO IgH RQ-PCR

✍ Scribed by Raponi, Sara; Della Starza, Irene; De Propris, Maria S.; Del Giudice, Ilaria; Mauro, Francesca R.; Marinelli, Marilisa; Di Maio, Valeria; Piciocchi, Alfonso; Foà, Robin; Guarini, Anna

Book ID: 123612223
Publisher: John Wiley and Sons
Year: 2014
Tongue: English
Weight: 293 KB
Volume: 166
Category: Article
ISSN: 0007-1048
DOI: 10.1111/bjh.12887

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Critical evaluation of ASO RQ-PCR for mi

Critical evaluation of ASO RQ-PCR for minimal residual disease evaluation in multiple myeloma. A comparative analysis with flow cytometry

✍ Puig, N; Sarasquete, M E; Balanzategui, A; Martínez, J; Paiva, B; García, H; Fum 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 896 KB

Comparative analysis of minimal residual

Comparative analysis of minimal residual disease detection using four-color flow cytometry, consensus IgH-PCR, and quantitative IgH PCR in CLL after allogeneic and autologous stem cell transplantation

✍ Böttcher, S; Ritgen, M; Pott, C; Brüggemann, M; Raff, T; Stilgenbauer, S; Döhner 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 280 KB

The assessment of minimal residual disea

The assessment of minimal residual disease in chronic lymphocytic leukaemia: comparison of multi-colour flow cytometry and bone marrow trephine biopsy

✍ E. Grey-Davies, A. Attygalle, A. Wotherspoon, F. Carretero, A. Morilla, C. Deard 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 372 KB

Stem cell transplantation in poor-risk c

Stem cell transplantation in poor-risk chronic lymphocytic leukemia: assessment of post-transplant minimal residual disease using four- and six-color flow cytometry and allele-specific RQ-PCR

✍ Maija Itälä; Anna-Riina Huhtinen; Vesa Juvonen; Veli Kairisto; Tarja-Terttu Pell 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 233 KB

5.38 Interest of Early Determination of

5.38 Interest of Early Determination of Bone Marrow Minimal Residual Disease by a Sensitive 6-Color Flow Cytometry in the Evaluation of Response: the Experience of the CLL2007FMP, an Intergroup Phase III Randomized Multicentric Trial Comparing Fludarabine, Cyclophosphamide, and Rituximab versus Fludarabine, Cyclophosphamide, and MabCampath in Previously Untreated B-Chronic Lymphocytic Leukemia Patients

✍ Remi Letestu; Stephane Leprêtre; Christine Arnoulet; Lucille Baseggio; Lydia Cam 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 81 KB